Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer

被引：0
|
作者：
Weiguo Sui
Minglin Ou
Jiejing Chen
Youhua Wan
Hongbo Peng
Minfang Qi
He Huang
Yong Dai
机构：
[1] 181st Hospital of People's Liberation Army,Laboratory Center of Guangzhou Military Area Command
[2] Guangxi Normal University,College of Life Science
[3] 181st Hospital of People's Liberation Army,Pathology Department of Guangzhou Military Area Command
来源：
World Journal of Surgical Oncology | / 7卷
关键词：
Trastuzumab; Human Epidermal Growth Factor Receptor; Invasive Ductal Carcinoma; Herceptin; Discordance Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Her-2/neu oncogene overexpression: Comparison of immunohistochemistry (IHC) with fluorescent in situ hybridization assay (FISH).
    Ashfaq, R
    Frenkel, E
    Saliger, F
    Thomas, S
    Saboorian, MH
    LABORATORY INVESTIGATION, 1999, 79 (01) : 15A - 15A
  • [22] Comparison of fluorescence in situ hybridization (FISH) with immunohistochemistry (IHC) for detection of HER2/neu amplification/overexpression in breast cancer.
    Sun, G
    Morales, JS
    Wilz, S
    McKee, C
    Amberson, J
    Gersen, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 107 - 107
  • [23] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Shanmugalingam, Aswin
    Hitos, Kerry
    Pathmanathan, Nirmala
    Edirimmane, Senarath
    Hughes, T. Michael
    Ngui, Nicholas K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (01) : 143 - 148
  • [24] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Aswin Shanmugalingam
    Kerry Hitos
    Nirmala Pathmanathan
    Senarath Edirimmane
    T. Michael Hughes
    Nicholas K. Ngui
    Breast Cancer Research and Treatment, 2023, 198 : 143 - 148
  • [25] Her-2/neu/evaluation in breast cancer: A comparison of immunohistochemical (IHC) determination and flourescence in situ hybridization (FISH).
    Mehta, A
    Mahadevia, S
    Cannizzaro, L
    Ramesh, KH
    Fineberg, S
    MODERN PATHOLOGY, 2001, 14 (01) : 32A - 32A
  • [26] Evaluation of HER-2/neu gene status in breast cancer by chromogenic in situ hybridization: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kokka, E
    Arvanitis, H
    Kouri, E
    LABORATORY INVESTIGATION, 2003, 83 (01) : 37A - 37A
  • [27] Comparative Assessment of Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Silver-Enhanced In Situ Hybridization (SISH) for Evaluation of HER2 Gene Status in Breast Carcinoma
    Ryu, Y.
    Jeong, H.
    Kim, Y.
    Kim, B.
    Kim, H.
    Kim, A.
    MODERN PATHOLOGY, 2010, 23 : 70A - 70A
  • [28] Comparative Assessment of Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Silver-Enhanced In Situ Hybridization (SISH) for Evaluation of HER2 Gene Status in Breast Carcinoma
    Ryu, Y.
    Jeong, H.
    Kim, Y.
    Kim, B.
    Kim, H.
    Kim, A.
    LABORATORY INVESTIGATION, 2010, 90 : 70A - 70A
  • [29] Evaluation of HER-2/neu gene status in breast cancer by chromogenic in situ hybridization: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kokka, E
    Arvanitis, H
    Kouri, E
    MODERN PATHOLOGY, 2003, 16 (01) : 37A - 37A
  • [30] Correlation of Her2/Neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    LABORATORY INVESTIGATION, 2005, 85 : 35A - 35A
12345